posted by mike kraft
on Thu, 2025-05-22 10:10
...vaccine maker Moderna announced (yesterday) it voluntarily pulled its licensing submission for the combination seasonal influenza–COVID-19 mRNA vaccine candidate, mRNA-1083, so that it can submit efficacy data.
The news comes a day after the US Food and Drug Administration announced that seasonal COVID-19 boosters would now be recommended only for adults ages 65 and older or for those who are at risk for severe COVID-19 because of underlying health conditions.
Moderna's combination vaccine was intended for adults 50 and older.
...
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
